These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32974985)

  • 21. Antioxidant network-based signatures cluster glioblastoma into distinct redox-resistant phenotypes.
    Yang Y; More S; De Smet F; De Vleeschouwer S; Agostinis P
    Front Immunol; 2024; 15():1342977. PubMed ID: 38698847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.
    Brown DV; Daniel PM; D'Abaco GM; Gogos A; Ng W; Morokoff AP; Mantamadiotis T
    Oncotarget; 2015 Mar; 6(8):6267-80. PubMed ID: 25749043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive understanding of glioblastoma molecular phenotypes: classification, characteristics, and transition.
    Xu C; Hou P; Li X; Xiao M; Zhang Z; Li Z; Xu J; Liu G; Tan Y; Fang C
    Cancer Biol Med; 2024 May; 21(5):363-81. PubMed ID: 38712813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autocrine platelet-derived growth factor-dependent gene expression in glioblastoma cells is mediated largely by activation of the transcription factor sterol regulatory element binding protein and is associated with altered genotype and patient survival in human brain tumors.
    Ma D; Nutt CL; Shanehsaz P; Peng X; Louis DN; Kaetzel DM
    Cancer Res; 2005 Jul; 65(13):5523-34. PubMed ID: 15994924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analyses identify molecular signature of MRI-classified SVZ-associated glioblastoma.
    Lin CA; Rhodes CT; Lin C; Phillips JJ; Berger MS
    Cell Cycle; 2017 Apr; 16(8):765-775. PubMed ID: 28278055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of glioblastoma (GBM) molecular classification methods.
    Lee E; Yong RL; Paddison P; Zhu J
    Semin Cancer Biol; 2018 Dec; 53():201-211. PubMed ID: 30031763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bayesian nonlinear model selection for gene regulatory networks.
    Ni Y; Stingo FC; Baladandayuthapani V
    Biometrics; 2015 Sep; 71(3):585-95. PubMed ID: 25854759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic estimates of aneuploid content in glioblastoma multiforme and improved classification.
    Li B; Senbabaoglu Y; Peng W; Yang ML; Xu J; Li JZ
    Clin Cancer Res; 2012 Oct; 18(20):5595-605. PubMed ID: 22912392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SYGNALing a Red Light for Glioblastoma.
    Brooks AN; Mueller WF; Steinmetz LM
    Cell Syst; 2016 Aug; 3(2):118-120. PubMed ID: 27559923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissecting inherent intratumor heterogeneity in patient-derived glioblastoma culture models.
    Teng J; da Hora CC; Kantar RS; Nakano I; Wakimoto H; Batchelor TT; Chiocca EA; Badr CE; Tannous BA
    Neuro Oncol; 2017 Jun; 19(6):820-832. PubMed ID: 28062830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Crucial Candidate Genes and Pathways in Glioblastoma Multiform by Bioinformatics Analysis.
    Alshabi AM; Vastrad B; Shaikh IA; Vastrad C
    Biomolecules; 2019 May; 9(5):. PubMed ID: 31137733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relevance of a TCGA-derived Glioblastoma Subtype Gene-Classifier among Patient Populations.
    Teo WY; Sekar K; Seshachalam P; Shen J; Chow WY; Lau CC; Yang H; Park J; Kang SG; Li X; Nam DH; Hui KM
    Sci Rep; 2019 May; 9(1):7442. PubMed ID: 31092847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTBP1-mediated repression of neuron-specific CDC42 splicing constitutes a genomic alteration-independent, developmentally conserved vulnerability in IDH-wildtype glioblastoma.
    Yang J; Feng J; Lv J; Chu X; Wei Y; Zhang Y; Li J; Sun Y; Li G; Jiang T; Huang J; Fan X
    Funct Integr Genomics; 2024 Aug; 24(4):135. PubMed ID: 39117866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison and analysis of lncRNA-mediated ceRNA regulation in different molecular subtypes of glioblastoma.
    Li Q; Yu Q; Ji J; Wang P; Li D
    Mol Omics; 2019 Dec; 15(6):406-419. PubMed ID: 31584593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas.
    Doucette T; Rao G; Rao A; Shen L; Aldape K; Wei J; Dziurzynski K; Gilbert M; Heimberger AB
    Cancer Immunol Res; 2013 Aug; 1(2):112-22. PubMed ID: 24409449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microenvironment-Derived Regulation of HIF Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme.
    Heiland DH; Gaebelein A; Börries M; Wörner J; Pompe N; Franco P; Heynckes S; Bartholomae M; hAilín DÓ; Carro MS; Prinz M; Weber S; Mader I; Delev D; Schnell O
    Mol Cancer Res; 2018 Apr; 16(4):655-668. PubMed ID: 29330292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastoma.
    Genovese G; Ergun A; Shukla SA; Campos B; Hanna J; Ghosh P; Quayle SN; Rai K; Colla S; Ying H; Wu CJ; Sarkar S; Xiao Y; Zhang J; Zhang H; Kwong L; Dunn K; Wiedemeyer WR; Brennan C; Zheng H; Rimm DL; Collins JJ; Chin L
    Cancer Discov; 2012 Aug; 2(8):736-49. PubMed ID: 22750848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kernel Differential Subgraph Analysis to Reveal the Key Period Affecting Glioblastoma.
    Xie J; Sun J; Feng J; Yang F; Wang J; Wen T; Nie Q
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32079293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular subtypes of glioblastoma are relevant to lower grade glioma.
    Guan X; Vengoechea J; Zheng S; Sloan AE; Chen Y; Brat DJ; O'Neill BP; de Groot J; Yust-Katz S; Yung WK; Cohen ML; Aldape KD; Rosenfeld S; Verhaak RG; Barnholtz-Sloan JS
    PLoS One; 2014; 9(3):e91216. PubMed ID: 24614622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of the potential oncogenes in glioblastoma based on bioinformatic analysis and elucidation of the underlying mechanisms.
    Zhang Y; Xia Q; Lin J
    Oncol Rep; 2018 Aug; 40(2):715-725. PubMed ID: 29901201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.